Botulinum toxin A and neuropathic pain: An update.
Toxicon
; 232: 107208, 2023 Aug 15.
Article
em En
| MEDLINE
| ID: mdl-37385479
ABSTRACT
Botulinum toxin type A is a widely used neurotoxin for the treatment of muscle hyperactivity such as dystonia and spasticity. Several clinical trials have also reported an efficacy of subcutaneous or intradermal administrations of botulinum toxin A on various neuropathic pain conditions including idiopathic trigeminal neuralgia and found that specific sensory phenotypes were predictors of the response. This narrative review summarizes the potential mechanisms of action, efficacy and safety of botulinum toxin A in neuropathic pain as well as its place in the therapeutic algorithm of neuropathic pain.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Toxinas Botulínicas Tipo A
/
Distonia
/
Neuralgia
/
Fármacos Neuromusculares
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article